Search

everythinglearnresearchcommunity

for

Search:↓

Estheticians in dermatology improve patient satisfaction and loyalty with proper training and planning.

Accurate diagnosis and tailored treatment are crucial for managing common primary care symptoms.

Wnt signaling is vital for cell growth, development, and cancer research.

The European Society of Endocrinology advises individualized long-term management for PCOS, focusing on lifestyle changes, accurate diagnosis, and treatments for associated health risks and symptoms.

Dehydroepiandrosterone (DHEA) is a prohormone important for producing sex steroids and has potential health benefits.

Hormone therapy for trans individuals is effective and generally safe in the short term.

Taxane chemotherapy can cause skin, hair, and nail side effects, which are often under-reported and can affect patient quality of life.

The update highlights that non-classic congenital adrenal hyperplasia is common in women with excess male hormones, requires specific hormone tests for diagnosis, and has various treatment options depending on age and symptoms.

Hair elemental analysis could be useful for health and exposure assessment but requires more standardization and research.

Lower SHBG levels may increase the risk of PCOS.

Pregnancy can increase lupus activity, but careful planning and treatment can improve outcomes.

Taking low-dose spironolactone and metformin together works better for PCOS symptoms than either drug alone.

Many young women who donate blood have hormonal disorders like excess male hormones and PCOS.

Oral dutasteride and topical pimecrolimus can safely and effectively treat Frontal Fibrosing Alopecia, leading to significant hair regrowth.

Nuclear hormone receptors play a significant role in skin wound healing and could lead to better treatment methods.

Skin problems are very common in people with end-stage kidney disease.

Adults with polycystic ovary syndrome are much more likely to have obstructive sleep apnea.

There are still challenges in diagnosing and treating chronic skin diseases, but there is hope for future improvements.

Lower levels of certain brain chemicals are linked to worse PTSD symptoms in men.

Botulinum toxin shows promise for various skin conditions but requires more research for confirmation and standardized use.

People with alopecia are at higher risk for heart disease and have more heart-related risk factors.

Women with PCOS have similar levels of certain proteins compared to women without PCOS, and these proteins don't independently cause PCOS.

Patients with acanthosis nigricans often have insulin resistance and signs of increased male hormones, but treatment targeting these male hormones is generally ineffective.

The research found that polycystic ovary syndrome (PCOS) has two distinct types, with one having more severe hormone and insulin issues.

Metformin improves menstrual cycles and hormone levels in women with PCOS, mostly within the first 6 months.

Men with benign prostatic hyperplasia are more likely to have metabolic syndrome than those without it.

Tralokinumab for atopic dermatitis may cause side effects like dizziness, headache, nausea, hair loss, and acne.

The research found that MRI and certain hormone levels can help tell apart ovarian tumors from hyperthecosis in postmenopausal women, but tissue analysis is still needed for a definite diagnosis.

Some skin disorders might be linked to H. pylori infection, but more research is needed to confirm this.

Mice with LSS deficiency showed hair loss and cataracts, similar to humans, and can help in understanding and treating this condition.